CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations a...
Phase 3
Cleveland, Ohio, United States and 80 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Cleveland, Ohio, United States and 97 other locations
to therapy acting directly on the anti-IL-4R. This will be conducted by examining the effect of a 48 week therapy with dupilumab on the rate of asthma...
Phase 4
Cleveland, Ohio, United States and 6 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Cleveland, Ohio, United States and 429 other locations
omalizumabTo evaluate the effect of dupilumab on asthma control at Week 24 compared to omalizumabTo evaluate the safety of dupilumab and om...
Phase 4
Cleveland, Ohio, United States and 94 other locations
A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patie...
Cleveland, Ohio, United States and 2 other locations
Clinical trials
Research sites
Resources
Legal